Chronic discrimination in both minority and non-minority populations is linked to adverse health outcomes, including increased risk of cardiovascular disease and increased mortality, but the biological processes through which discrimination affects health are unclear. The current study tested the hypothesis that discrimination in a sample of Caucasians would predict elevated serum levels of E-selectin, an indication of endothelial dysfunction which itself is associated with atherosclerosis and cardiovascular disease risk. Participants (N = 804) in the biomarker sample from the Survey of Midlife in the United States (MIDUS) provided information about experiences of both major and everyday discrimination at two times separated by a 9-10 year interval. The discrimination measures were designed to assess perceived unfair treatment (e.g. being fired unfairly) independently of the perceived reasons for the unfair treatment (e.g. race, gender). Serum E-selectin was measured at the second wave of data collection. Women reported significantly more instances of major (P < 0.05) and everyday P < 0.001) discrimination than men. Analyses of Covariance (ANCOVA) showed that both greater lifetime exposure to major discrimination (P < 0.05) and chronic exposure to everyday discrimination (P < 0.05) predicted higher circulating levels of E-selectin, but only in men. These associations remained statistically significant after adjustments for potential confounding variables, including age, race, socioeconomic status, health status, and health behavior. These results highlight a potential biological mechanism by which exposure to unfair treatment may be related to health, particularly cardiovascular function. Moreover, they add to a growing literature suggesting that unfair treatment in general may predict adverse health outcomes.
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Introduction
Discrimination has been convincingly linked to a range of adverse health outcomes (Williams et al., 2003; Paradies, 2006) , and the ways in which discrimination can affect health are myriad. Institutionalized discrimination, for example, can affect the health of entire segments of the population by way of reduced access to health care, sub-standard living conditions, and diminished opportunities for socioeconomic advancement (Krieger, 2001; Ahmed et al., 2007) . At the individual level, exposure to unfair treatment or the perception of unfair treatment may act as a potent stressor that has adverse effects on health and longevity. In communitydwelling samples of African American women, for example, chronic exposure to discrimination is positively associated with risk factors for cardiovascular disease, including elevated blood pressure (Guyll et al., 2001) , increased carotid intima media thickness (Troxel et al., 2003) , and coronary artery calcification (Lewis et al., 2006) . Perceived discrimination is also associated with increased risk of mortality in older adults (Barnes et al., 2008) . To date, however, little is known about how -i.e. through what biological processes -unfair treatment is linked to adverse health outcomes, including elevated cardiovascular risk. The current study focuses on E-selectin, a marker for one candidate pathway: endothelial dysfunction.
E-selectin is one of a family of cell adhesion molecules (CAMs) that are expressed on the surfaces of endothelial cells as part of the inflammatory response to endothelial damage, and expression of these proteins is one indication of potential adverse changes in endothelial homeostasis, also known as endothelial dysfunction
